We are live on ! Find out more
EARNEST Partners

EARNEST Partners Portfolio holdings

AUM $24.3B
1-Year Est. Return 34.41%
This Fund
S&P 500
This Quarter Est. Return
+25.6%
1 Year Est. Return
+34.41%
3 Year Est. Return
+66.51%
5 Year Est. Return
+86.35%
10 Year Est. Return
+426.93%
AUM
$10.6B
AUM Growth
+$1.71B
Cap. Flow
-$200M
Cap. Flow %
-1.89%
Top 10 Hldgs %
16.54%
Holding
1,223
New
42
Increased
117
Reduced
189
Closed
43

Top Buys

Rank Stock Value
1
PBR icon
Petrobras
PBR
+$63M
2
CBRL icon
Cracker Barrel
CBRL
+$59.8M
3
SABR icon
Sabre
SABR
+$57.8M
4
R icon
Ryder
R
+$55M
5
PLXS icon
Plexus
PLXS
+$41.5M

Top Sells

Rank Stock Value
1
EBS icon
Emergent Biosolutions
EBS
+$92.4M
2
ICLR icon
Icon
ICLR
+$73.9M
3
BHP icon
BHP
BHP
+$58.6M
4
CHKP icon
Check Point Software Technologies
CHKP
+$50.1M
5
RCI icon
Rogers Communications
RCI
+$44.9M

Sector Composition

Rank Sector Weight
1 Technology 21.65%
2 Financials 18.46%
3 Industrials 16.65%
4 Healthcare 10.85%
5 Consumer Discretionary 10.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSLA icon
276
Tesla
TSLA
$1.18T
$75K ﹤0.01%
1,035
+180
+21% +$9.74K
UFPT icon
277
UFP Technologies
UFPT
$1.97B
$75K ﹤0.01%
1,700
– –
INO icon
278
Inovio Pharmaceuticals
INO
$85.6M
$74K ﹤0.01%
229
– –
ATSG
279
DELISTED
Air Transport Services Group
ATSG
$73K ﹤0.01%
3,300
– –
TMO icon
280
Thermo Fisher Scientific
TMO
$214B
$72K ﹤0.01%
199
– –
LLY icon
281
Eli Lilly
LLY
$1.08T
$70K ﹤0.01%
428
– –
NEE icon
282
NextEra Energy
NEE
$185B
$69K ﹤0.01%
1,144
– –
BMY icon
283
Bristol-Myers Squibb
BMY
$129B
$67K ﹤0.01%
1,147
– –
ACN icon
284
Accenture
ACN
$106B
$66K ﹤0.01%
306
– –
AMGN icon
285
Amgen
AMGN
$209B
$66K ﹤0.01%
280
– –
MCD icon
286
McDonald's
MCD
$193B
$66K ﹤0.01%
358
– –
SCZ icon
287
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.1B
$65K ﹤0.01%
1,220
– –
COST icon
288
Costco
COST
$432B
$61K ﹤0.01%
201
– –
MDT icon
289
Medtronic
MDT
$112B
$60K ﹤0.01%
657
– –
AGI icon
290
Alamos Gold
AGI
$12B
$59K ﹤0.01%
6,300
– –
AVGO icon
291
Broadcom
AVGO
$1.76T
$59K ﹤0.01%
1,860
-150
-7% -$4.2K
ANIK icon
292
Anika Therapeutics
ANIK
$215M
$57K ﹤0.01%
1,500
– –
NKE icon
293
Nike
NKE
$64.1B
$56K ﹤0.01%
569
– –
LIN icon
294
Linde
LIN
$236B
$55K ﹤0.01%
259
– –
MGPI icon
295
MGP Ingredients
MGPI
$404M
$55K ﹤0.01%
1,500
– –
TXN icon
296
Texas Instruments
TXN
$248B
$54K ﹤0.01%
425
-67
-14% -$7.81K
C icon
297
Citigroup
C
$213B
$53K ﹤0.01%
1,033
-87
-8% -$4.13K
ESCA icon
298
Escalade
ESCA
$271M
$53K ﹤0.01%
3,810
– –
HON icon
299
Honeywell
HON
$76.4B
$53K ﹤0.01%
387
– –
LOW icon
300
Lowe's Companies
LOW
$121B
$53K ﹤0.01%
395
– –
10 11
12
13 14

Similar funds

JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $24.3B AUM 29.21% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
CS
Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

EARNEST Partners's Q2 2020 Portfolio in Review

As of Q2 2020, EARNEST Partners held 1,223 positions worth $10.6B, up 19% from $8.87B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

EARNEST Partners's Q2 2020 filing shows 42 new, 117 increased, 189 reduced and 43 closed positions. Its largest new stake was Cracker Barrel: 602,889 shares worth $66.9M. The largest sale was Emergent Biosolutions, an estimated $92.4M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Financials and Industrials.

  • EARNEST Partners's largest Q2 2020 buy was Cracker Barrel: 602,889 shares worth $66.9M.
  • EARNEST Partners added most to Petrobras in Q2 2020, an estimated $63M increase.
  • EARNEST Partners's biggest Q2 2020 reduction was Emergent Biosolutions, cutting an estimated $92.4M.
  • EARNEST Partners fully exited ATI in Q2 2020, selling an estimated $5.17M.
  • EARNEST Partners's ten largest holdings make up 17% of its $10.6B portfolio in Q2 2020.
  • EARNEST Partners opened 42 new positions and closed 43 in Q2 2020.
  • EARNEST Partners's portfolio value rose 19% quarter-over-quarter to $10.6B.

Based on EARNEST Partners's 13F filing for Q2 2020, filed 13 Aug 2020.